熱門資訊> 正文
Tilray Medical推出Tilray Medical Italia，进军意大利
2026-01-22 19:42
- Tilray Medical, a division of Tilray Brands (TLRY), announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the entity formerly known as FL Group.
- The move to Tilray Medical Italia underscores the company’s effort to build a unified medical cannabis platform across Europe while strengthening its presence in one of the region’s key regulated markets.
- Tilray Medical Italia is expanding its footprint in Italy through a growing portfolio of medical cannabis products authorized by the Italian Ministry of Health and supported by a partnership with Molteni Farmaceutici.
More on Tilray
- International Cannabis Expansion Gives Tilray Positive 2026 Outlook
- Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
- Wall Street Lunch: Craft Beers Enter 2026 On Choppy Waters
- Tilray anticipates $150M global medical cannabis revenue run rate as international expansion accelerates
- Tilray rises as it achieves record quarterly revenue on cannabis sales growth
推薦文章
美股機會日報 | 凌晨3點！美聯儲將公佈1月貨幣政策會議紀要，納指期貨漲近0.5%；13F大曝光！巴菲特連續三季減持蘋果
美股機會日報 | 阿里發佈千問3.5！性能媲美Gemini 3；馬斯克稱Cybercab將於4月開始生產
港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%
一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報
從軟件到房地產，美國多板塊陷入AI恐慌拋售潮
Meta計劃為智能眼鏡添加人臉識別技術
危機四伏，市場卻似乎毫不在意
財報前瞻 | 英偉達Q4財報放榜在即！高盛、瑞銀預計將大超預期，兩大關鍵催化將帶來意外驚喜？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
